Literature DB >> 20473872

Prevention of new hepatocellular carcinoma with concomitant antiviral therapy in chronic hepatitis B patients whose initial tumor was successfully ablated.

Hie-Won Hann, Diane Bergin, Robert Coben, Anthony J DiMarino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20473872     DOI： 10.1002/ijc.25382

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  10 in total

1.  Radiofrequency ablation plus nucleotide analogous for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis.

Authors:  Baoxian Liu; Mengchao Wei; Furong Liu; Shuling Chen; Zhenwei Peng; Bin Li; Qian Zhou; Haibo Wang; Sui Peng; Ming Kuang
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

Review 2.  Then and now: the progress in hepatitis B treatment over the past 20 years.

Authors:  Dina Halegoua-De Marzio; Hie-Won Hann
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 3.  Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection.

Authors:  Yang Ke; Lin Wang; Le-Qun Li; Jian-Hong Zhong
Journal:  World J Hepatol       Date:  2014-09-27

4.  Detection of urine DNA markers for monitoring recurrent hepatocellular carcinoma.

Authors:  Hie-Won Hann; Surbhi Jain; Grace Park; Jamin D Steffen; Wei Song; Ying-Hsiu Su
Journal:  Hepatoma Res       Date:  2017-06-06

5.  Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia.

Authors:  Xinhui Wang; Xiaoli Liu; Peng Wang; Lihua Yu; Fengna Yan; Huiwen Yan; Dongdong Zhou; Zhiyun Yang
Journal:  J Hepatocell Carcinoma       Date:  2021-10-21

Review 6.  Hepatitis B Virus-Associated Hepatocellular Carcinoma and Chronic Stress.

Authors:  Nicholas Noverati; Rukaiya Bashir-Hamidu; Dina Halegoua-DeMarzio; Hie-Won Hann
Journal:  Int J Mol Sci       Date:  2022-04-01       Impact factor: 5.923

7.  Antiviral therapy improves the survival rate and decreases recurrences and fatalities in liver cancer patients following curative resection: A meta-analysis.

Authors:  Hao Zhang; Yuchen Zhou; Guosheng Yuan; Guangyao Zhou; Dinghua Yang; Yuanping Zhou
Journal:  Mol Clin Oncol       Date:  2015-07-30

8.  A long-term study of the effects of antiviral therapy on survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation.

Authors:  Hie-Won Hann; Robert Coben; Daniel Brown; Laurence Needleman; Ernest Rosato; Albert Min; Richard S Hann; Kyong Bin Park; Stephen Dunn; Anthony J DiMarino
Journal:  Cancer Med       Date:  2014-02-12       Impact factor: 4.452

Review 9.  Nucleot(s)ide analogues for hepatitis B virus-related hepatocellular carcinoma after curative treatment: a systematic review and meta-analysis.

Authors:  Ping Sun; Xiaochuan Dong; Xiang Cheng; Qinggang Hu; Qichang Zheng
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

Review 10.  Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure.

Authors:  Brianna J Shinn; Aaron Martin; Robert M Coben; Mitchell I Conn; Jorge Prieto; Howard Kroop; Anthony J DiMarino; Hie-Won Hann
Journal:  World J Hepatol       Date:  2019-01-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.